Investigation of nausea and vomiting in cancer patients undergoing chemotherapy
Nausea and vomiting are the most impor tant problems in patients undergoing chemotherapy, despite the recent improve ments in the administration of antiemetic drugs. Through a review of the literature, we found that there are several nursing research es focusing on the effectiveness of interven tions for the treatment of nausea and vomiting in cancer patients. The purpose of this study was to investigate the symptom of nausea and vomiting in patients undergoing chemothera py. The study also investigated the impact of nausea and vomiting on patients’ ability to respond to daily activities. The study is descriptive; the sample included patients with different types of cancer and receiving chemotherapy. The inclusion criteria were: the histological diagnosis of cancer, the adminis tration of chemotherapy and the knowledge of the Greek language. The questionnaires used were: the MASCC (vomiting questionnaire), the Memorial Symptom Assessment Scale and the scale of functional assessment of cancer therapy. Data collection took place in oncologi cal hospitals of Thessaloniki and Athens in Greece. For statistical analysis we used the statistical package SPSS 15.0.
1. American Cancer Society. Cancer facts and figures. 2012. Available form: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf
2. WHO. GLOBOCAN 2012: section of cancer information. Available from: http://globo-can.iarc.fr/Default.aspx
3. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.
4. NCCN. NCNN clinical practice guidelines in oncology. 2012. Available from: http://www.nccn.org/professionals/physi-cian_gls/f_guidelines.asp
5. Lohr J. Chemotherapy-induced nausea and vomiting. Cancer J 2008;14:85-93.
6. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008;358:2482-94
7. Feyer P, Jordan K. Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol 2011;22:30-8.
8. Roila F, Hersted J, Aapro M, et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010;21:232-43.
9. Martin, CG, Rubenstein ED, Elting LS, et al. Measuring chemotherapy-induced nausea and emesis. Psychometric properties of a quality of life questionnaire. Cancer 2003;98:645-55.
10. Molassiotis A, Saunders MP, Valle J, et al. A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 2008;16:201-8.
11. Hickok JT, Roscoe JA, Morrow GR, et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemesis: a University of Rochester James P. Wilmot Cancer center community clinical oncology program study of 360 cancer patients treated in the community. Cancer 2003;97:2880-6.
12. Tipton JM, Mcdaniel RW, Barbour L, et al. Putting evidence into practice: evidence-based interventions to prevent, manage and treat chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs 2007;11:69-78.
13. Vidal C, Dielensenger P, Farell C, et al. Evidence-based management of chemotherapy-induced nausea and vomiting: a position statement from a European cancer nursing forum. Ecancermedicalscience 2001;5:211.
14. Genc A, Can G, Aydiner A. The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting. Support Care Cancer 2013;21:253-61.
15. Yeh CH, Chien LC, Chiang YC, et al. Reduction in nausea and vomiting in children undergoing cancer chemotherapy by either appropriate of shum acupuncture points with standard care. J Alter Com Med 2012;18:334-40.
16. Suh EE. The effects of P6 acupressure and nurse-provided counseling on chemotherapy-induced nausea and vomiting in patients with breast cancer. Oncol Nurs Forum 2012;39:E1-9.
17. Glaus A, Knipping C, Morant R, et al. Chemotherapy-induced nausea and vomiting in routine practice: a European perspective. Support Care Cancer 2004;12:708-15.
18. Molassiotis A, Brearley SG, Stamataki Z. Use of antiemetics in the management of chemotherapy-related nausea and vomiting in current UK practice. Support Care Cancer 2011;19:949-56.
19. Pectasides D, Dafni U, Aravantinos G, et al. A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin. Anticancer Res 2007;27:4411-7.
20. Stathopoulos GP, Antoniou D, Dimitroulis J, et al. Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Ann Oncol 2010;21:2227-32.
21. Katsenos, S, Psara, A, Panagou, C. Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment. Oncol Pharm Pract 2013;19:93-4.